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 1
INTRODUCTION 
 
 
Myocardial Infarction is a serious complication of 
Atherosclerotic Coronary Heart Disease. Coronary Heart Disease 
was first described by William Heberden in 1768. In 1932 unipolar 
leads were discovered by Wilson and the establishment of coronary 
care units by Day and Brown has lead to the world wide proliferation 
of coronary care units. The current knowledge of pathophysiology of 
acute myocardial infarction started with the autopsy description of 
Dr. James Herrick from Chicago in 1912 who concluded that acute 
myocardial infarction results from thrombotic occlusion of coronary 
artery and prophesised that the hope of salvaging the muscle lay in 
restoration of blood flow. 
 Myocardial Infarction9 is an acute cardiac disability arising 
from reduction or arrest of blood supply to the myocardium due to 
atherosclerotic or non-atherosclerotic lesions of coronary arteries. 
Virtually all acute infarcts are caused by thrombosis developing in a 
culprit vessel with ruptured atherosclerotic plaque. Usually coronary 
artery occlusion is associated with infarction of myocardium, though 
post-mortem examination of cases of sudden deaths reveals evidence 
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in only 20% of cases, the remaining 80% do not showing any 
change. 
 Accurate diagnosis is mandatory because mistaken diagnosis 
can be disastrous to the social, economical and family life of the 
patient. At one end of the spectrum is the danger of missing a 
potentially lethal illness, on the other hand mistaken diagnosis results 
in severe cardiac neurosis which is even more difficult to treat than 
the original disease itself. 
 The presenting symptoms may vary from severe pain in the 
chest to minimal symptoms, with the disease remaining 
unrecognized. In most patients there is a substernal heaviness14 
which radiates to the left shoulder or ulnar surface of forearm and 
hand. It can also radiate to back, interscapular region, root of neck, 
jaw and teeth. In others it presents as breathlessness, syncope, 
giddiness, fatigue, abdominal pain, nausea, vomiting and 
unexplained hypotension. 
 Coronary Heart Disease is more age dependant in women than 
in men. Women are usually 10 years older than men when any 
coronary manifestation first appears and Myocardial Infarction 
occurs as much as 20 years later ⁵⁵. Coronary Heart Disease is the 
leading cause of death in women and the lifetime risk of death is 
 3
31% in postmenopausal women. The median age of menopause is 
51.4 years10 and age distribution ranges from 40-58 years.  
Data from Framingham study says that the incidence of 
cardiovascular disease is 3 times lower in women than men before 
menopause and approximately equal in men and women aged 75-79 
years. The incidence in women rises after menopause due to 
hormonal changes, resulting in increase in LDL Cholesterol, 
enhancement of oxidation of LDL Cholesterol and fall in HDL 
levels. 
 Overall mortality and morbidity in coronary heart disease 
depends on age, sex, site and extent of infarction, presence of good 
collateral circulation and associated co-morbid conditions. 
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AIM OF THE STUDY 
 
1.To analyze various risk factors in women with Myocardial 
Infarction. 
2.To study the incidence, presenting features, site of infarction, and                   
complications of the disease. 
3.To study mortality in women with Acute Myocardial Infarction. 
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REVIEW OF LITERATURE 
 
1. ANATOMY OF CORONARY 
CIRCULATION 
 
         The epicardial coronary arteries take origin from the right and 
left coronary sinuses. In 85% of patient the right coronary artery 
which gives rise to posterior descending artery supplies the entire 
right ventricle and large a part of the posterior wall of the left 
ventricle. This is referred to as right dominant circulation. 
 In 8% of patients the left coronary artery supplies entire left 
ventricle, interventricular septum and portion of right ventricle. This 
is referred to as left dominant circulation. 
 In 7% of patients referred to as co-dominant circulation, the 
right coronary artery supplies right ventricle and posterior wall of 
interventricular  septum while left coronary supplies the left ventricle 
and anterior portion of interventricular septum. 
B. AETIOPATHOGENESIS OF  
     MYOCARDIAL INFARCTION 
 
1. ATHEROSCLEROSIS19, 11  
Atherosclerosis is characterized by formation of atheroma or 
fibro fatty plaque which consists of a raised focal plaque within the 
 6
intima, having a core of lipid and a covering fibrous cap. 
 Atherosclerosis2, 15 is the single most aetiological factor for 
coronary heart disease. The search for the cause and pathogenesis of 
atherosclerosis has become an insistent “golden grail”. The 
acceptable hypotheses are 
A) LIPID INSUDATION OR INFILTRATION HYPOTHESIS: 
 
          This is the modified “imbibition hypothesis”7 termed by 
Virchow in 1856 which stated that cellular proliferation in intima 
was a form of low grade inflammation as a reaction to increased 
infiltration of plasma protein and lipids from the blood. 
B) ENCRUSTATION OR THROMBOGENIC HYPOTHESIS: 
 
 This theory ascribed to Rokitansky, postulated that small 
thrombi composed of platelet, fibrin and leukocytes collected over 
foci of endothelial injury organized and their gradual growth resulted 
in plaque formation. 
C) REACTION TO INJURY HYPOTHESIS: 
 
This widely accepted theory formulated by Ross and Glomset 
in 1976 and modified in 1986 states that the lesions of atherosclerosis 
are initiated as a response to some form of injury to arterial 
endothelium. Endothelial injury leads to attachment of monocytes 
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and platelets, proliferation of smooth muscle cells in the arterial 
intima and deposition of intracellular and extracellular lipids. 
2. NON-ATHEROSCLEROSIS 3 
 
 Non-atherosclerotic causes of Myocardial infarction are 
1) Congenital anomalies like single coronary artery, atresia 
of coronary ostium, myocardial bridges, coronary AV 
fistula etc. 
2)  Dissection of coronary artery or aorta. 
3)  Embolic phenomena from prosthetic valves, infective 
endocarditis, tumors, calcium, paradoxical embolus, etc. 
4) Traumatic injury or spasm of coronary artery. 
5) Coronary arteritis due to Takayasu Disease, Polyarteritis 
Nodosa, SLE, Syphilis, Kawasaki Disease 
6) Metabolic disorders like Mucopolysaccharidoses, 
Homocystinuria, Fabry’s Disease and Amyloidosis. 
7) Substance abuse like cocaine, amphetamine. 
8) Myocardial oxygen demand-supply disproportion due to 
aortic stenosis, systemic hypotension, carbon monoxide 
poisoning, thyrotoxicosis. 
9) Intimal proliferation due to irradiation, cardiac 
transplantation, fibro muscular hyperplasia. 
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10) Miscellaneous cause like HOCM, hypercoagulable 
states, diabetes mellitus.  
C. RISK FACTORS FOR MYOCARDIAL 
INFARCTION 1, 16, 17 
 
 The term risk is widely used to describe those 
characteristically found in healthy individuals that relate to the 
subsequent appearance of Ischaemic Heart Disease¹. The risk of 
Ischaemic Heart Disease is determined by the aggregation of 
individual factors. 
Table1: RISK FACTORS FOR CORONARY HEART DISEASE 
A. FIXED 
1. Age 
2. Male sex 
3. Family History 
B. MODIFIABLE 
1. Smoking 
2. Hypertension 
3. Lipid Disorders 
4. Diabetes Mellitus 
5.Haemostatic variables 
6. Sedentary Life Style 
7. Obesity 
8. Mental Stress 
9. Personality 
10. Oral Contraceptive Pills 
11. Hyperhomocysteinemia 
12. Inflammation 
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1. AGE: 
 
 Age  is a definite unmodifiable risk factor. Atherosclerosis 
develops progressively as age advances. Atherosclerosis is rarely 
present in early childhood, except in familial hyperlipidemia, but it is 
often detectable in postmortem specimens of young age between 15-
30 years. Atherosclerosis is universal in elderly. 
2. SEX: 
 Men are more affected than premenopausal women. However 
after menopause the incidence of atheroma rises in women. This 
suggests that oestrogen probably plays a part in preventing or 
delaying atherosclerosis. There is also a fall in HDL levels in 
postmenopausal women which may also contribute. 
3. FAMILY HISTORY: 
 Coronary artery disease runs in families. This may be due to 
genetic factors or the effects of a shared environment (similar diet, 
smoking habits etc,). A positive family history is generally accepted 
to refer to those in whom a first degree relative of the patient has 
developed Ischaemic Heart Disease before the age of 50 years8. 
4. SMOKING: 
Tobacco is probably the most important avoidable cause of 
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coronary disease. The incidence of Ischaemic Heart Disease is 3-5 
times higher in smokers who smoke 20 cigarettes per day compared 
to non-smokers. There is a strong, consistent and dose linked 
relationship between cigarette smoking and ischaemic heart disease. 
The incidence of sudden death is also higher in smokers and may be 
the first manifestation of the disease. Smoking decreases HDL 
cholesterol levels. It accelerates atherosclerosis, plaque instability, 
increases the risk of thrombosis, myocardial infarction and death.  
Women cigarette smokers are also at greater risk of developing 
coronary artery disease than non-smokers. In those who smoke and 
also use oral contraceptives the risk increases many fold. 
Continuation of smoking increases incidence of restenosis after 
Percutaneous Transluminal Coronary Angioplasty and Coronary 
Artery Bypass Grafting. The relative risk is highest in young people 
and becomes significantly lower within 6 months of quitting. 
5. HYPERTENSION:  
 The incidence of coronary heart disease increases as blood 
pressure rises and the excess risk is related to both systolic and 
diastolic blood pressure. In the Framingham study, the incidence of 
Coronary Artery Disease in middle aged persons with blood pressure 
exceeding 160/95mmHg was 5 times more than that in normotensive 
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men.  For each 10mmHg increase in Diastolic Blood Pressure there 
is 37% increase in risk of Coronary Heart Disease26. 
Antihypertensive drugs have shown to reduce coronary mortality 
particularly by interruption of renin angiotensin system. 
6. LIPID DISORDERS: 
 A diet rich in saturated fat and cholesterol is associated with 
increased incidence of atherosclerosis. There also appears to be a 
genetic variation in the ability of dietary cholesterol to influence 
plasma cholesterol and atherosclerosis. 
 A wealth of evidence from epidemiological, clinical and 
experimental studies has established the association between 
hyperlipidemia and atherosclerosis. Hypercholesterolemia is clearly a 
risk factor. 
 Of the lipoprotein, it is the low density lipoprotein (LDL) 
which is most atherogenic. VLDL is comparatively less atherogenic. 
HDL offers a protective effect and helps in removing cholesterol 
from the arterial wall. The ratio of LDL/HDL is a common way to 
assess atherogenicity of hyperlipidemia. A ratio of more than 4.5 is 
supposed to be atherogenic. A minor increase of 1mg/dl in HDL-4 
Cholesterol produces a 2-4% decrease in the risk of developing 
Acute Myocardial Infarction. 
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 The LDL cholesterol profiles are categorized as phenotypic 
pattern A, B and C. Patients with pattern B have mostly small, dense 
LDL particles. Small, dense LDL particles have been causally linked 
to an increased risk of coronary artery disease independent of total 
LDL cholesterol levels. The phenotype B pattern is often, but not 
always associated with elevated triglycerides and triglyceride rich 
lipoproteins, reduced HDL and other features of insulin resistance 
syndrome. It has been suggested that small dense LDL particles are 
more atherogenic because of greater retention in the arterial wall and 
increased susceptibility to oxidation. 
 There is increasing evidence that hypertriglyceridemia is 
independently linked with coronary atheroma even after adjustment 
for HDL levels. In Indians living in India or abroad, raised 
triglycerides with low HDL has been found to be atherogenic.   
 7. DIABETES MELLITUS: 
 Diabetes Mellitus22 is a coronary heart disease risk equivalent. 
The abnormal lipid profile with insulin resistance known as Diabetic 
Dyslipidemia (small dense LDL, low HDL, elevated triglyceride) 
account for part of elevated cardiovascular risk. Diabetes increases 
the frequency of atherosclerosis. It is likely that post prandial 
hyperglycemia may be more important in the development of 
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coronary artery disease than fasting hyperglycemia.  Diabetic women 
are 5-6 times more prone for coronary heart disease27compared to 
men. 
8. HAEMOSTATIC FACTORS: 
 High levels of fibrinogen and factor 7 are associated with 
increased risk of myocardial infarction. Polymorphism of factor 7 
gene may increase the risk of Myocardial Infarction8. The stability of 
an arterial thrombus depends on the balance between fibrinolytic 
factors like plasmin and inhibitors of the fibrinolytic system such as 
Plasminogen Activator Inhibitor (PAI) 1. However, the levels of 
tissue plasminogen activator and PAI-1 in plasma have not proven to 
add information beyond the lipid profile for assessment of 
cardiovascular risk. 
 Apolipoprotein (a) has structural homology with plasminogen 
with which it is able to compete for cell surface binding. By 
displacing plasminogen, apolipoprotein(a) is able to inhibit cell 
surface mediated endogenous fibrinolysis by reducing the formation 
of Plasminogen Activator from Plasminogen.  
Plasma level of Lp(a) is largely genetically determined. Lp (a) 
levels do not potently predict risk in the population at large. 
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9. SEDENTARY LIFE STYLE: 
 The recent National Institute of Health Consensus Panel on 
Physical Activity and Cardiovascular Health established a goal of 
atleast 30 min of moderate intensity physical activity on a daily 
basis. Exercise increases HDL cholesterol, lowers blood pressure, 
reduces blood clotting and promote collateral vessel development. 
10. OBESITY: 
 Obesity5, particularly the male pattern centripetal or visceral 
fat accumulation is probably an independent risk factor although it 
can be associated with hypertension, diabetes mellitus and physical 
inactivity. 
11. MENTAL STRESS AND PERSONALITY: 
 Stress is associated with increased catecholamine levels and 
high blood pressure thereby increasing the risk of coronary heart 
disease. 
 Type A individual who are ambitious, aggressive, impatient, 
competitive, always in a hurry and often frustrated are more prone to 
ischaemic heart disease. 
12. ORAL CONTRACEPTIVE PILLS: 
Oral contraceptives disturb the clotting mechanism through an 
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increased inactivity of factor 7 and 10. It also increases platelet 
sensitivity to ADP and hence to platelet adhesiveness. Oestrogen 
retards atherosclerosis but accelerates thrombogenesis resulting in 
myocardial infarction in the rare susceptible person. 
13. HYPERHOMOCYSTEINEMIA: 
 A large body of literature suggests a relationship between 
hyperhomocysteinemia and coronary events. Several mutations in the 
enzymes involved in homocysteine accumulation correlate with 
thrombosis and in some studies, coronary risk. Measurement of 
homocysteine levels should be reserved for individuals with 
atherosclerosis at a young age or out of proportion to established risk 
factors. 
14. INFLAMMATION: 
 An accumulation of clinical evidence shows that markers of 
inflammation correlate with coronary risk. Inflammatory cells in the 
plaque may contribute to plaque destabilization by producing matrix 
degrading metalloproteinases and by inducing smooth muscle cell 
apoptosis. Inflammatory cells also contribute to plaque 
thrombogenicity by releasing tissue factor a procoagulant protein that 
activates the clotting cascade resulting in thrombin generation which 
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leads to platelet aggregation and fibrin deposition. Inflammation in 
atherosclerotic plaque may be incited by a number of factors, which 
include oxidized LDL, cigarette smoking and possibly infectious 
agents. Variation of plasma levels of CRP can prospectively predict 
risk of myocardial infarction. CRP levels also correlate with outcome 
of patients with acute coronary syndrome. Elevated levels of the 
acute phase reactant CRP may merely reflect ongoing inflammation 
rather than a direct etiologic role of CRP in the coronary artery 
disease. 
 One source of inflammatory stimulus could arise from 
infectious agents. Interest has resurged in the possibility that 
infections may cause or contribute to atherosclerosis. Recent 
evidences support the role of Chlamydia pneumoniae, 
Cytomegalovirus, Herpes virus, H.Pylori or other infectious agents in 
atherosclerosis and restenosis following coronary intervention. 
 Chronic bronchitis and chronic gingivitis (most often due to 
infection with Porphyromonus gingivalis) have also been linked to 
atherosclerotic vascular disease. These have been linked to Acute 
Coronary events based on seroepidemiologic data or identification of 
the organism in the atherosclerotic plaque. 
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D. CLINICAL FEATURES 
 
 Retrosternal chest discomfort is the cardinal symptom of 
myocardial infarction, but breathlessness, vomiting, giddiness, 
syncope are common features. Patient is anxious and experiences the 
fear of impending death. Syncope is usually due to arrhythmia or 
profound hypotension. Vomiting and sinus bradycardia are often due 
to vagal stimulation and are particularly common in patients with 
inferior wall myocardial infarction. Many deaths occur within the 
first hour. Development of cardiac failure reflects the extent of 
myocardial damage and is the major cause of death in those who 
survive the first few hours of infarction. On examination signs of 
sympathetic activity like sweating, tachycardia may be present. 
Vomiting and bradycardia may also be present. Signs of impaired 
myocardial function like hypotension, oliguria, cold peripheries, 
raised JVP, muffled heart sounds, S3, basal crepitations, pansystolic 
murmurs may also be present. Pericardial rub may be present. 
 
E.INVESTIGATIONS 
 
1. LABORATORY FINDINGS: 
 
Myoglobin levels are the earliest to rise. Creatine Kinase starts 
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to rise at 4 hours, peaks at about 12 hours fall to normal levels within 
48-72 hours 18. The most sensitive markers of myocardial cell 
damage are the Cardiac Troponins T and I which are released within 
4-6 hours and remain elevated for upto 2 weeks. Myoglobin levels 
peak at 6 hours and returns to normal at 24 hours. Aspartate 
transaminase starts to rise about 12 hours after infarction and reaches 
peak on the first or second day returning to normal within 3 or 4 
days. Lactate dehydrogenase peaks at 3-4 days remains elevated for 
upto 10 days. 
 Lipid profile (cholesterol – total, LDL & triglycerides) may be 
raised. Leukocytosis is usual, reaching a peak on the first day. The 
ESR becomes raised. 
2. CHEST RADIOGRAPHY: 
 Chest X-ray is important since it may show the consequences 
of ischaemic heart disease i.e. cardiac enlargement, ventricular 
aneurysm, signs of heart failure and pericardial effusion. These signs 
can support the diagnosis of ischaemic heart disease and are 
important in assessing the degree of cardiac damage. 
3. ELECTROCARDIOGRAPHY: 
 The  ECG is  usually a  sensitive  and  specific  way  of  
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confirming the diagnosis; however it may be difficult to interpret if 
there is bundle branch block or evidence of previous myocardial 
infarction. Occasionally the initial ECG is normal and the diagnostic 
changes appear a few hours later. The earliest ECG change is tall and 
widened T waves followed by ST elevation. Later on there is 
diminution in the size of R wave and in full thickness infarction a Q 
wave begins to develop. Subsequently T wave becomes inverted. 
 When there has been anteroseptal infarction abnormalities are 
found in one or more leads from V1 to V4, while Anterolateral 
Infarction produces abnormalities in V4-V6, aVL and in lead I. 
Inferior Wall Infarction is best shown in lead II, III and aVF, while at 
the same time leads I, aVL and the anterior chest leads may show 
reciprocal changes of ST depression. 
  Infarction of the posterior wall of the left ventricle is not 
recorded in the standard leads by ST elevation or Q waves, but the 
reciprocal changes of ST depression and a tall R wave may be seen 
in leads V1-V3. 
  Right ventricular infarction should be strongly suspected if, in 
the clinical setting of acute inferior wall myocardial infarction, there 
is ST elevation of 1mm or more in lead V1,V4R or any of the extra 
right precordial leads V4R-V6R. 
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4. ECHOCARDIOGRAPHY: 
 Two dimensional echocardiography can be done to assess the 
cardiac chamber size, regional wall motion abnormalities, left 
ventricular hypertrophy, valve leaflet thickness and mobility, valve 
calcification, appearance of subvalvular and supravalvular structures, 
pericardial effusion, intracardiac masses and great vessels. 
  Doppler echocardiography is done to assess valve 
regurgitation, valve stenosis, valve area, valve gradients, intracardiac 
pressures, intracardiac shunts and ventricular diastolic filling. 
 Transesophageal echocardiography is used to assess aortic 
disease, infective endocarditis, to find out source of embolism, 
abnormalities of mitral prostheses etc.  
 Stress echocardiography is done to find out new regional wall 
motion abnormalities, declining ejection fraction and increase in end 
systolic volume which are indicators of myocardial ischemia. 
5. RADIONUCLIDE SCANNING: 
 A radionuclide ventriculogram can be used to assess left 
ventricular function. Infarct ‘avid’ scanning is possible because some 
isotopes (e.g. Technetium) are taken up by freshly infarcted 
myocardium. This may help to establish the diagnosis in some 
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patients who present after a cardiac arrest when it is sometimes 
difficult to interpret any ECG and enzyme changes. 
 
F. COMPLICATIONS OF MYOCARDIAL 
INFARCTION ¹ 
 
1. ARRHYTHMIAS: 
A. TACHYARRYTHMIAS: 
a. Premature ventricular complexes: 
 The commonest arrhythmia is premature ventricular 
complexes. This can be suppressed with IV lignocaine 100mg given 
as bolus. To prevent recurrence lignocaine infusion of 500-1000mg 
in 500ml of 5% dextrose is administered at a rate of 1-2mg/min. 
premature ventricular complexes can be forerunners of life 
threatening ventricular tachycardia or ventricular fibrillation. 
b. Ventricular Tachycardia: 
 It needs immediate attention and should be treated by IV 
lignocaine. In case the drug is ineffective, DC shock of 150-200 
joules will be effective in majority of the cases. Repeated attacks of 
ventricular tachycardia can be prevented by IV infusion of 
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lignocaine, amiodarone or mexilitene. Ventricular pacing may also 
be effective. 
c. Ventricular Fibrillation: 
 The patient is pulseless and will have features of cardiac arrest. 
Immediate thump on the chest and an external cardiac massage is 
required. Defibrillation should be one by DC shock of 200-400 
joules. Patients with repeated episodes may benefit from intravenous 
bretylium, amiodarone, mexilitene or lignocaine. 
d. Supraventricular Arrhythmias: 
 Atrial premature beats do not need specific treatment. 
However supraventricular arrhythmia, atrial flutter and atrial 
fibrillation require treatment with digoxin or verapamil. 
e. Accelerated Ventricular or Junctional Rhythm: 
 Normally pace maker cells in the AV junctional and 
ventricular myocardium have a rate of 40-6-/min. however in the 
settings of myocardial infarction, especially in acute inferior wall 
myocardial infarction, the rate of these pacemakers increases to 
about 80-120/min. such a rhythm do not require specific treatment 
and is normally self limiting. If hemodynamic compromise occurs 
IV atropine (1.2mg) suppresses it by increasing the sinus rate. 
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B. BRADYARRHYTHMIAS AND CONDUCTION 
DISTURBANCES: 
a. Sinus Node Dysfunction: 
 It may present as sinus bradycardia, sinus arrest or sinoatrial 
block usually due to vagal stimulation or in the settings of inferior 
wall infarction due to sinus node ischaemia. Symptoms of profound 
hypotension and shock may occur and occasionally asystole and 
cardiac arrest. Immediate treatment consists of IV atropine (1.2mg). 
If atropine is ineffective or this problem is persistent or recurring 
temporary pace making is necessary. 
b. AV Nodal Block: 
 It usually occurs with inferior wall myocardial infarction as 
first degree AV block, wenkebach’s block or complete AV block. 
These blocks are usually transient and respond to IV atropine. If 
giddiness, hypotension or other evidence of hemodynamic 
compromise occurs or if the ventricular rate is less than 50/min 
temporary pacing may be required. 
c. Distal Conduction Disturbances: 
 The distal conduction system consists of the right bundle and 
the anterior and posterior fascicles of the left bundle. Since the 
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major blood supply to this part of the conduction system comes from 
the left coronary artery, conduction defects in the bundle branches 
are common in anterior wall infarction.  
Block of one of the fascicles of the left bundle does not have 
an ominous prognosis. However acute right or left bundle branch 
block or bifascicular block carries an ominous prognosis. Block in 
the three fascicles results in complete heart block with an unstable 
ventricular escape rhythm at a rate of 20-4- beats per minute.    
Clinical manifestations consists of syncopal attacks, hypotension 
and may lead to cardiac arrest. Temporary pacemaker insertion is 
necessary. Temporary pacing is also indicated in patients who 
develop bifascicular blocks since this can be a precursor of 
trifascicular block. Patients with bifascicular block who develop 
trifascicular block may need permanent pacemaker implantation. 
2. ISCHAEMIA: 
 
 Post infarction angina occurs in upto 50% of patients. This is 
due to residual stenosis in infarct related vessel despite successful 
thrombolysis. 
3. ACUTE CIRCULATORY FAILURE: 
 
Hemodynamic evidence of left ventricular dysfunction appears 
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when contraction is seriously impaired in 20-25% of the left 
ventricle.  
Infarction of more than 40% of left ventricle results in 
Cardiogenic Shock which carries a bad prognosis. 
4. PERICARDITIS: 
 This may occur at any stage but is particularly common on the 
second and third day. The patient may recognize a different pain that 
is positional and worsens on inspiration. 
 Dressler’s Syndrome may occur between 2 weeks and 3 
months after acute myocardial infarction 12 and has an autoimmune 
basis often accompanied by pleural and pericardial effusions, fever 
and raised ESR. Treatment requires the use of steroids. 
5. MECHANICAL COMPLICATIONS: 
a. Mitral regurgitation: 
 It is due to ischaemia or rupture of papillary muscle and is 
recognized by the presence of systolic murmur at the apex. If trivial, 
it is of no hemodynamic significance. However severe mitral 
regurgitation can induce life threatening left ventricular failure and 
cardiogenic shock and may warrant urgent coronary angiography 
followed by coronary bypass surgery and mitral valve replacement. 
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b. Ventricular septal defect: 
 It is a defect due to rupture of infarcted interventricular septum 
and is recognized by the presence of pansystolic murmur at the left 
sternal border. Diagnosis is possible by Echo-Doppler studies. It 
produces severe left heart failure and needs immediate surgical 
intervention. 
c. Cardiac Rupture: 
 It is a serious complication which results in cardiogenic shock 
and almost 100% mortality. Emergency treatment by pericardial 
tapping may prove life saving. Rare cases have been saved by 
emergency surgery. 
 
6. OTHER COMPLICATIONS: 
a. Left Ventricular Aneurysm: 
 The infarcted segments are dilated and show paradoxical 
movement and compromised left ventricular hemodynamics. It is 
recognized by persistent ST elevation in ECG and dyskinesia seen in 
echocardiography and radionuclide or contrast ventriculography. It 
may result in persistent left ventricular failure, arrhythmias and 
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systemic embolism. Treatment consists of anerysmectomy and 
associated coronary artery bypass surgery if so indicated. 
b. Thromboembolism: 
 Formation of a thrombus within the left ventricle followed by 
systemic arterial embolism leading to occlusion of a peripheral artery 
requires immediate surgical embolectomy in accessible vessels.
 Pulmonary embolism originates in the leg veins due to 
prolonged immobilization. These are prevented by anticoagulation. 
Massive embolism may result in shock and sudden death. 
Thrombolytic therapy and embolectomy are occasionally required. 
The condition can be prevented by low molecular weight heparin. 
 
G. CORONARY HEART DISEASE IN        
     WOMEN: 
 Women with heart disease may present differently than men, 
have unique underlying pathophysiologies and have distinctive risk 
benefit profiles with commonly accepted therapies. Heart disease is 
far more age dependant in women than in men. Women with 
cardiovascular disease are older and have more co-morbidity. This 
fact, in turn, makes diagnostic and treatment procedures more 
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problematic in women. In addition, may effective pharmacological 
strategies are underutilized and there is a lack of gender specific data 
on numerous therapies. Clinicians have long known of the apparent 
protection of younger, premenopausal women from ischaemic heart 
disease and this protection   has been attributed to oestrogen. Further 
nuclear oestrogen receptors are present in cardiac myocyte of males 
and females, a potential explanation for gender differences in gene 
regulation. However these physiological differences have failed to 
translate into a useful pharmacopoeia. 
 Two genes were relevant in women – Plasminogen activator 
inhibitor 1 (PAI-1) and Stromelysin-1. Such genetic differences are 
manifest in the physiology of atherosclerosis, including plaque 
components (more cellular and fibrous tissue in women), endothelial 
function (oestrogen induced coronary vasodilation) and hemostasis 
(higher fibrinogen and factor 7 levels in women). Women are twice 
more likely to have plaque erosion than men. 
 Women are older and have a greater burden of risk factors and 
concomitant disease, they are more frail and less likely to recover 
fully from cardiovascular events. Women’s greater longevity and our 
society’s gender roles combined to make women caregivers to men 
but often leave the same women without social, emotional or 
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financial support at the time of their own illness. Women, as well as 
their caregivers may underestimate the importance of atherosclerotic 
disease and fail to implement the preventive strategies fully or even 
recognize and act on symptoms appropriately. These factors have a 
significant negative impact on optimal care delivery for women. 
 Coming to the risk factors diabetes is associated with a greater 
incremental risk in women completely eliminating the female 
advantage. The American Heart Association awards double weight to 
diabetes in women when calculating coronary heart disease risk. The 
population risk attributable to hypertension is higher in women than 
men because of the increased incidence with age and longevity of 
women. Cigarettes have an antiestrogenic effect and induce an 
unfavorable lipid profile, leading women to lose their “natural” 
protection against atherosclerotic vascular disease. The average lipid 
profile in women is affected by hormonal status and changes 
throughout life. Young women have lower LDL and higher HDL 
than men of same age. As women ages LDL increases, HDL 
decreases and the risk of coronary heart disease climbs. 
Triglycerides, Lp (a), Apolipoprotein B-100 and Apolipoprotein (a) 
is also associated with higher cardiac risk in women. Higher 
oestrogen, oxytocin levels, lower iron levels have been suggested to 
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afford protection against coronary heart disease in premenopausal 
females. Obesity is associated with increased CRP particularly in 
women. Physical inactivity is more prevalent among women than 
men. 
 Women have a different clinical presentation and hospital 
course following acute coronary syndrome and acute myocardial 
infarction and respond differently to medical and procedural 
therapies. Women are likely to be older and are more likely to have a 
history of systemic hypertension, diabetes mellitus, unstable angina, 
hyperlipidemia and congestive cardiac failure. Women are also more 
likely to experience jaw, neck and shoulder pain, abdominal pain, 
nausea, vomiting, palpitation, fatigue and dyspnoea in addition to 
chest pain and are less likely to report diaphoresis than men. 
Although chest pain is the single most common presenting symptom 
of myocardial infarction in women, women seem more susceptible to 
silent infarction particularly elderly women. Perhaps in part because 
of these more atypical symptoms women seek medical attention 
more slowly and even after hospital arrival may experience greater 
delays in receiving care. Physicians’ uncertainty about the true 
clinical diagnosis is more common for women than men with acute 
myocardial infarction and misdiagnosis is more likely. 
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 Women with infarction have higher risk initial presentations, 
with greater prevalence of tachycardia, rales, heart block of higher 
Killips class. Women have higher rates of in-hospital complications 
from infarction including bleeding, stroke, shock, myocardial rupture 
and recurrent chest pain than do men although most of these 
differences appear attributable to age and co-morbidities. There is a 
two fold greater mortality in women younger than 50 years compared 
with similarly aged men. Mortality 1-3 years after hospital discharge 
is also increased in younger women, although it is similar in 
postmenopausal women and men. Women are more likely than men 
to experience vascular and renal complications form diagnostic 
angiography. 
 Eligible women now seem to receive thrombolytic therapy at 
rates equal to those of men, but women more frequently have 
contraindications to thrombolysis. Primary angioplasty is more 
effective in women. Percutaneous revascularization has the similar 
efficacy as in men but the procedural complications remain higher. 
The difference in outcome has been variously attributed to women’s 
older age, smaller body size, greater severity of angina, more fragile 
vessels and greater burden of co-morbidity. In-hospital mortality for 
coronary artery bypass graft is 1.4 to 4.4 times higher particularly in 
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women less than 60 years. Women are less likely to receive internal 
mammary grafts and undergo complete revascularization and are 
more likely to experience the complications of heart failure, 
perioperative infarction and hemorrhage. Neurological complications 
of coronary artery bypass graft, including stroke, transient ischaemic 
attack and coma are more frequent in women. Rehospitalization rates 
for women are two times those for men in the first two months after 
coronary artery bypass grafting. The causes for higher operative 
mortality and morbidity appear to be multiple including technical 
factors such as smaller body size and coronary diameter, advanced 
age and co-morbid factors and clinical factors such as the urgency of 
the procedure. After coronary artery bypass graft women have a 
lower likelihood of being free of angina than do men and experience 
greater physical disability and less return to work.. 
Improvement in prevention of coronary artery disease in 
women requires earlier awareness and identification of the risk. 
Social networks and support influence coronary heart disease 
outcome both independently and through the likelihood of 
compliance of therapeutic strategies (e.g. cardiac rehabilitation) and 
their impact may be greater in women. 
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MATERIAL AND METHODS 
During the period from 1st Jan 2005 to 31st Dec 2005 sixty five 
female patients were admitted with acute myocardial infarction in 
coronary care unit, CMC Hospital, Coimbatore. These cases were 
taken up for study and they were divided into two groups. 
GROUP A: Includes Premenopausal women. 
GROUP B: Includes Postmenopausal women. 
 In the present study, the WHO criterion 4 was followed to 
diagnose myocardial infarction in women. Among the following 
criteria atleast two of the three had to be present for accepting the 
case as myocardial infarction. 
1. Typical history of retrosternal chest pain. 
2. Serial ECG changes 23, 24, 25: Appearance of pathological Q wave 
or appearance of ST elevation with T wave inversion in atleast 2 
or more leads. 
3. Raised CPK-MB taken 12-24 hours after the onset of symptoms. 
 After careful history taking, physical signs were recorded in 
detail. History of prolonged hypertension, diabetes was taken into 
consideration. History of oral contraceptive intake, tobacco chewing, 
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cigarette smoking were noted. Family history of IHD, hypertension, 
diabetes, obesity, and sudden death were also noted. 
 Menstrual history, obstetric history, year and month of 
menopause, were recorded. Serum analysis of cholesterol and blood 
sugar along with enzyme studies were done within 24 hours of 
admission. Chest X-ray and Echocardiography were taken in all 
cases. 
 Serum cholesterol was considered to be increased if it was 
greater than 200mgm%. Waist circumference more than 88cm was 
taken as obese. The type and extent of infarction were judged by the 
Q wave and ST elevation in serial ECGs. 
 Once diagnosis was established routine management was 
carried out which included bed rest, oxygen therapy, sedation with 
narcotics, coronary vasodilator, thrombolytic and antiplatelet 
treatment. Blood pressure and pulse were recorded and continuous 
ECG monitoring was done for the first 48 hours along with ½ hourly 
pulse, blood pressure, temperature and respiration recording. 
 A careful observation was made on all patients for the 
development of arrhythmias, left ventricular failure, cardiogenic 
shock and other complications. They were treated accordingly. 
 A detailed record of the illness was maintained. 
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OBSERVATIONS 
 
A. RISK FACTORS 
 
1. MENSTRUAL HISTORY: 
 
  In the present study 14 (21.5%) women were 
menstruating (Group A). 51 (78.5%) women had attained menopause 
(Group B). The incidence of myocardial infarction was higher in the 
postmenopausal women. 
2. AGE: 
 
 Age is a definite risk factor. Total number of patients in this 
series was 65. Maximum number was in the 55-65 year age group 
(35.4%). 46-55 year age group comes next (23%). The incidence was 
less below 35 years and above 75 years. The youngest patient was 35 
year and the oldest patient was 79 years. 
Table2: AGE DISTRIBUTION OF PATIENTS 
S.No AGE 
GROUP 
No. OF 
PATIENTS 
PERCENTAGE 
1 26-35 2 3 
2 36-45 12 18.4 
3 46-55 15 23 
4 56-65 23 35.4 
5 66-75 10 15.4 
6 ABOVE 75 3 4.6 
 TOTAL 65 100 
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3. FAMILY HISTORY: 
 Coronary artery disease was often found in several members of 
the same family. In this study, family history of diabetes was noted 
in 24 (36.9%) patients, hypertension in 28 (43%) patients, obesity in 
14 (21.5%) patients, and myocardial infarction in 15 (23%) patients. 
 4. ORAL CONTRACEPTIVE PILLS: 
 
 In the present study 5 (7.7%) were taking oral contraceptive 
pills for more than 3 months. All of them were premenopausal 
women.  
5. CIGARETTE SMOKING: 
 In the present study only 3 (4.6%) were cigar smokers and all 
were postmenopausal. There was no smoker in the premenopausal 
group. 
6. TOBACCO CHEWING: 
 In the present study 15 (23%) patients were taking tobacco for 
a long period (more than 3 months).  
Only 1 (7.1%) of the 14 premenopausal women took tobacco. 
14 (27.4%) of the 51 postmenopausal women took tobacco. 
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7. ABDOMINAL OBESITY: 
 In this study the waist circumference was recorded for all 
patients. Waist circumference more than 88cm (35in) was taken as 
abdominal obesity. 
 In the present study 20 (30.8%) patients were obese. Out of the 
14 premenopausal women 9 (64.3%) were obese. 11 (21.5%) out of 
the 51 postmenopausal women were obese. So obesity is a major risk 
factor in the premenopausal group. 
8. DIABETES MELLITUS: 
 In the present study, information regarding the prevalence of 
manifest diabetes was obtained from the interviews.  The patient was 
considered diabetic when there was a history of polyuria, polyphagia, 
and polydypsia, treatment with insulin or oral hypoglycemic agents. 
Increased blood sugar was also taken into consideration. ADA 2005 
guidelines were followed. 
 In the present series 27 (41.5%) patients were Diabetic. 6 
(42.9%) out of 14 premenopausal women were Diabetic. 21 (41.2%) 
out of 51 postmenopausal women were diabetic. So diabetes had an 
important role both in the premenopausal and postmenopausal 
groups. 
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9. HYPERTENSION: 
 In the present series blood pressure was routinely checked for 
minimum three consecutive days. Hypertension was noted in 26 
(40%) patients. Hypertension was noted in 6 (42.9%) out of 14 
premenopausal women. 20 (39.2%) out of 51 postmenopausal 
women had hypertension. So hypertension is an important risk factor 
in both groups. 
10. SERUM CHOLESTEROL: 
 In the present study cholesterol levels were raised in 25 
(38.5%) patients. Hypercholesterolemia was seen in 7 (50%) out of 
14 premenopausal patients, while it was present in 18 (35.3%) 
patients out of 51 postmenopausal female patients. 
Hypercholesterolemia was present in both groups particularly more 
in the premenopausal women. 
11. MULTIPLICITY OF RISK FACTORS: 
 Multiplicity of risk factors leading to angina pectoris and 
myocardial infarction are common in women. In the present study 
multiple risk factors were seen in all the members in the 
premenopausal group.  14 (27.5%) out of 51 postmenopausal women 
had no risk factors. 
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Table3: RISK FACTORS IN BOTH GROUPS 
 
 
Premenopausal 
women 
Postmenopausal 
women 
 
No. of 
Risk 
Factors 
No. of 
Patients % 
No. of 
Patients % 
NIL NIL NIL 14 27.5 
1 NIL NIL 1 2 
2 5 35.7 10 19.6 
3 3 21.4 10 19.6 
4 or More 6 42.9 16 31.4 
 14  51  
 
 
B.SYMPTOMATOLOGY 
 
1. PRESENTING FEATURES 
 
 
Table4: PRESENTING FEATURES IN BOTH GROUPS 
 
S.NO PRESENTING 
FEATURES 
NO.OF 
PATIENTS 
1 RETROSTERNAL PAIN 60 
2 RADIATION 30 
3 SWEATING 40 
4 NAUSEA &VOMITING 19 
5 DYSPNOEA 36 
6 BASAL CREPITATIONS 22 
7 GALLOP RYTHM 15 
8 ELEVATED JVP 07 
9 GIDDINESS 20 
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It has been stated that myocardial infarction is often atypical in 
women (Jouve.A.et al). But in the present study retrosternal pain was 
present in most cases. Characteristic features of myocardial 
infarction like sweating, radiation of pain, nausea, vomiting, and 
giddiness were present in a large number of cases. There was no 
difference in symptomatology between premenopausal and post 
menopausal women. 
 
C. INVESTIGATIONS 
 
1. ENZYME CHANGES: 
 
 CPK-MB levels were done for all the 65 cases .For diagnosis 
of Acute Myocardial Infarction CPK-MB values should be more than 
10IU/L.  
 
Table5: ENZYME STUDY WITHIN 24 HOURS OF 
ADMISSION 
 
 
ENZYME NO.OF 
CASES 
ABNORMAL 
RISE 
PERCENTAGE 
CPK-MB 65 49 75.4 
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2. X-RAY FINDINGS: 
 
               Chest x-ray was taken in all the 65 cases. The 
following findings were noted. 
 
 
Table6: CHEST X-RAY FINDINGS 
 
 
S.NO ABNORMALITY No. OF CASES 
1 Pulmonary venous congestion 22 
2 Cardiomegaly 20 
3 Calcified aortic knuckle 5 
 
3. ECHOCARDIOGRAPHY: 
 
 2D and Doppler Echocardiography was done for all 65 cases. 
All cases showed regional wall motion abnormality. Left ventricular 
dysfunction was noted in 22 cases out of which 4 were severe. 2 
cases showed Mitral Regurgitation. Left ventricular hypertrophy was 
noted in 20 cases. 
4. SITE OF INFARCTION: 
 
 The most common site of infarction in the present study 
was in the anteroseptal region. Second common site of infarction was 
in the inferior wall.  
 
 42
Table7: SITE OF INFARCTION IN BOTH GROUPS 
 
 
S.NO SITE OF 
INFARCTION 
NO.OF 
CASES 
PERCENTAGE 
1 ANTERO SEPTAL 31 47.7 
2 ANTERO LATERAL 6 9.2 
3 EXTENSIVE ANTERIOR 7 10.8 
4 INFERIOR WALL WITHOUT RVMI 11 16.9 
5 INFERIOR WALL WITH RVMI 7 10.8 
6 INFERO LATERAL 3 4.6 
7 TRUE POSTERIOR NIL NIL 
 TOTAL 65 100 
  
D. COMPLICATIONS:  
 Arrhythmia- 19 cases 
a) Ventricular premature beats- 7 
b) Ventricular tachycardia- 6 
c) Ventricular fibrillation- 2 
d) Atrial ectopics- 4 
 Cardiogenic shock- 5 cases 
 Acute left ventricular failure- 4 cases 
 Cardiac arrest- 1 case 
 First degree heart block-5 cases  
 Papillary muscle dysfunction- 2 cases 
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E. MORTALITY: 
  Robinson. K. and colleagues noticed that women with acute 
myocardial infarction showed a higher rate of complications and 
mortality than men 
 In the present study also it was found that mortality was seen 
in 5 (7.69%) out of 65 patients. 1 (7.14%) out of 14 premenopausal 
women and 4 (7.84%) out of 51 postmenopausal women died. 
Mortality was higher in 56 – 65 year age group. 
 
Table8: MORTALITY IN BOTH GROUPS 
 
 
 
 
 
 
 
 
 
 
 
 
# -
 Percentage calculated for 14 patients in premenopausal 
group 
 
$- Percentage calculated for 51 patients in postmenopausal 
group 
 
 
S.NO AGE GROUP 
IN YEARS 
NO. OF     
PATIENTS 
% 
1 26 - 35 NIL NIL 
2 36 – 45 1 7.14 # 
3 46 – 55 1 1.96 $ 
4 56 – 65 2 3.92 $ 
5 66 – 75 1 1.96 $ 
6 ABOVE 75 NIL NIL 
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Table9: CAUSE OF DEATH IN BOTH GROUPS 
 
 
S.No CAUSE OF 
DEATH 
NO OF 
PREMENOPA
USAL WOMEN 
NO OF 
POSTMENOPA
USAL WOMEN 
1 LVF 1 1 
2 VENTRICULAR 
FIBRILLATION 
NIL 1 
3 CARDIOGENIC 
SHOCK 
NIL 2 
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DISCUSSION 
 
 Myocardial Infarction in women is much less when 
compared to men. So the risk factors, clinical features, course of the 
illness have not been studied extensively but due to the change in life 
style and cultural factors the incidence of myocardial infarction in 
females is on the rise.  
              In the present series 65 women with Myocardial Infarction 
who were admitted in intensive coronary care unit, CMC Hospital, 
Coimbatore -18, during the period between 1st Jan 2005 to 31st Dec 
2005 with typical history, enzyme and ECG changes showing 
evidence of Myocardial Infarction were included. 
  The patients were divided into two groups as 
Premenopausal (Group A) and Postmenopausal (Group B). There 
were 14 Premenopausal and 51 Postmenopausal women in this study.  
1) AGE:  
 In the present study 35.4% were between 55 – 65 years. 
The incidence above 75 years was 4.6% and below 45 years was 
21.4%. 
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 Khyati et al (IHJ 2004) 28 who studied the risk factors in 
women with coronary artery disease noted that the mean age was 
53.8 ± 6.9 years.  
 Tumulu B Narayan et al (IHJ 2004) 29 in his study noted 
that the mean age was 55 ± 14 years. 
 Jaume Marrugat et al (JAMA 1998) 42 in their study noticed 
that the mean age in women was 68.6 years. 
 Age is a definite risk factor and the incidence increases 
after the age of 50 years. 
2. FAMILY HISTORY:  
 In the present study positive family history of Hypertension 
was noted in 43%, Obesity in 21.5%, Diabetes in 36.9%, and 
Myocardial Infarction in 23% patients. 
 Burke.G.C.et al (Circulation 1991) 30 noticed that positive 
family history of Hypertension was present in 56%, Obesity in 44%, 
Diabetes in 17% and Myocardial Infarction in 13% women. 
  So family history is a definite risk factor in both Western 
and Our studies. Family history of hypertension scores over others in 
the development of coronary artery disease. 
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3. ORAL CONTRACEPTIVE PILLS: 
 In the present study 7.69% of the women were taking oral 
contraceptive pills for more than 3 months. The details of the dose 
could not be elicited. All of them were premenopausal (GroupA). 
 Nicholas Dunn et al (BMJ 1999) 31 in his study noticed that 
there was no significant increased risk of myocardial infarction in 
users of oral contraceptives. 
 Bea C.Tanis et al (NEJM 2001) 32 noticed that the risk of 
myocardial infarction among users of any type of oral contraceptives 
was twice that of non users. 
 Jordanka et al (Int.J.Epi 1989) 34 in their study noticed that 
there is 2.48 times increased risk of myocardial infarction among the 
users of Oral Contraceptives. 
 Oomman et al (JAPI 2003) 33 noticed that out of 660 
females in his study 71% patients used oral contraceptives.  
 In this study the incidence is very low due to the low use of 
oral contraceptive pills among Indian women. 
4. SMOKING: 
 In the present study only 4.6% were cigar smokers. All 
belonged to the postmenopausal group . 
 48
 Croft.P.et al (BMJ 1989) 35 observed that among smoking 
women the risk of Myocardial Infarction is 1.7 times more in light 
smokers and 4.3 times more in heavy smokers, compared to 
nonsmokers. 
 N.R.Dunn et al (Heart 1999) 36 noticed a 2.47 times 
increased risk of Myocardial Infarction in smokers of 1-5 
cigarettes/day to 74.6 times increased risk in smokers who smoke 40 
cigarettes/day. It is estimated that if all women aged 16-44 yrs were 
able to stop smoking 400 cases of Myocardial Infarction per annum 
would be prevented. 
 Leroy Nickles et al (Ac. Em. Med 2004) 37 who conducted 
the study in young women less than 50 yrs noticed that 77% were 
smokers.  
 In the Indian study by Prabakaran.D.et al (IHJ 1991) 41 
mentioned that among women with smoking habit the risk of 
myocardial infarction was only 4.3%. 
 Smoking in Indian women is less because of cultural 
reasons. So the incidence is low compared with Western study. 
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5. TOBACCO CHEWING: 
 In this present study 23% were tobacco chewers. The 
incidence was 7.1% among premenopausal and 27.4% among the 
postmenopausal group. 
 Bolinder et al (Euro. Heart Journal 1992) 38 noted increased 
risk of death from coronary heart disease due to use of smokeless 
tobacco. 
 Tobacco chewing is common among South Indians. It is a 
definite risk factor for coronary artery disease. 
6. ABDOMINAL OBESITY: 
 In the present study 30.8% women had abdominal obesity. 
64.3% of the premenopausal group and 21.5% of the postmenopausal 
group had abdominal obesity. 
 Fraser B.E. et al (Circulation 1992) 39 pointed out that 
obesity is more closely associated with myocardial infarction in 43% 
of female patients. 
 Kathryn M. Rexrode et al (JAMA1998)40 noted that a waist 
circumference of 96.5cm or more was associated with a relative risk 
of 3.06. He concluded that waist circumference was independently 
associated with risk of coronary heart disease in women. 
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 Dave.T.H. et al (IHJ1991) 41 noted that the relationship 
between Myocardial Infarction and Obesity is 58.3% in Indian 
women. Oomman et al (JAPI 2003) 33 in his study done on 660 
women noted that 41% was obese. 
 Comparing the Western and Indian studies with the present 
study it shows that abdominal obesity is a definite risk factor. In the 
present study abdominal obesity is particularly a definite risk factor 
in Premenopausal women. 
7. DIABETES MELLITUS: 
 In this series 41.5% were Diabetic. The incidence was 
42.9% among the premenopausal (GroupA) and 41.2% among the 
postmenopausal women. 
 Jaume Marrugat et al (JAMA 1998) 42 noticed in their study 
that 52.9% women with myocardial infarction had diabetes. 
 Leroy Nickles et al (Ac.Em.Med 2004) 37 in their study 
conducted in young women less than 50 yrs noticed that 26.8% had 
Diabetes. 
 Oomman et al (JAPI 2003) 33 noted diabetes mellitus in 
52% of the cases and it was a predominant risk factor in 
postmenopausal women. 
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  A Chennai based study by Khyati et al (IHJ 2004) 28 
conducted on 50 women with coronary heart disease revealed that 29 
women were diabetic. 
 Shankar Krishnaswami 21 in the community based study 
sponsored by ICMR using 1995 urban and 3686 rural individuals 
around Vellore area noticed that diabetes was the risk factor in 7.3% 
urban females and 1.3% rural females. 
 Bobby John et al (IHJ 2004) 44 conducted a study on 324 
women with coronary heart disease and found that 140 (43.2%) 
patients had diabetes mellitus. 
 Comparing the result of Western studies, Indian study and 
the present study diabetes mellitus is a definite risk factor in both the 
groups. 
8. HYPERTENSION: 
 In the present study hypertension was noted in 40% 
women. The incidence was 42.9% among premenopausal women 
and 39.2% among postmenopausal women. 
 Jaume Marrugat et al (JAMA 1998) 42 noted in their study 
that 63.9% of women who had myocardial infarction were 
hypertensive. 
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 Croft.P.et al (BMJ 1989) 35 noted that among women with 
hypertension, the risk of myocardial infarction is 2.4 times more than 
those without risk factors. 
 In a study conducted by Oommam et al (JAPI 2003) 33 in 
660 females 60% had hypertension which was a predominant risk 
factor in postmenopausal women. 
 Alkesh Jain et al (IHJ 2004) 43 who conducted a risk factor 
profile study in Indian females noted that 38% women had 
hypertension. 
 Bobby John et al (IHJ 2004) 44 who conducted a study on 
324 women  with coronary heart disease noticed that 201 (62%) 
women had hypertension. 
 Comparing the result of Western and Indian studies with 
the present study, hypertension is a definite risk factor in women 
with coronary artery disease. 
9. HYPERCHOLESTEROLEMIA: 
 In this present series 38.5% patients had serum cholesterol 
values more than 200mgm%. The incidence among Premenopausal 
women was 50% and it was 35.3% among the Postmenopausal 
women. 
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 Assmann.G.et al (AHJ 1988) 45 conducted a study among 
1333 women and observed that 43.27% had hypercholesterolemia. 
They were followed up and out of which 74% developed Myocardial 
Infarction later. 
 Miller.M.et al (Circulation 1992) 46 conducted a study 
among 24 women for a period of 13 years and noticed that 45% of 
them who developed Myocardial Infarction had 
hypercholesterolemia. 
 Bobby John et al (IHJ 2004) 44 conducted a study on 
coronary heart disease in Indian women over a 2 year period in 324 
women and noted that 130 women (40.1%) had total cholesterol 
more than 200mgm%. 
 Khyati et al (IHJ 2004) 28 noted in their study that 24 
women out of 50 women with coronary heart disease were 
hypercholesterolemic. 
10. MULTIPLE RISK FACTORS: 
 In this study, the analysis of multiple risk factors showed 
that 2 or more were present in 100% of Premenopausal and 70.6% of 
Postmenopausal women. 3 or more risk factors were present in 
64.3% of Premenopausal and 51% of Postmenopausal women. 4 or 
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more risk factors were noted in 42.9% Premenopausal and 31.4% of 
Postmenopausal women. 
 Croft.P.et al (BMJ 1989) 35 noted that relative risk of 
smoking in Myocardial Infarction was 1.7 times for light smokers 
and 4.3 times for heavy smokers and in combined smoking and oral 
contraceptive use the relative risk is 20.8 times and smoking with 
toxemia of pregnancy the relative risk of Myocardial Infarction was 
41 times. 
 Chasan Taber et al (NEJM 2001) 47 noted that heavy 
smokers who used oral contraceptive pills had risks that were atleast 
30 times as high as those of women with neither risk factor. 
 N.R.Dunn et al (Heart 1999) 36 noticed that there was an 
additive risk of Myocardial Infarction in smokers with other clinical 
risk factors such as Hypertension and Diabetes. 
 Leroy Nickles et al (Ac.Em.Med 2004) 37 noticed that there 
was atleast one risk factor in all Acute Myocardial Infarction cases of 
the Premenopausal group and 87% had 2 or more risk factors. 
 Tumulu B. Narayan et al (IHJ 2004) 29 noted in their study 
on 318 women that 81 women had Diabetes, 174 women had 
Hypertension, 99 women had Dyslipidemia, and 51 women had a 
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previous history of Myocardial Infarction. They noted that clustering 
of risk factors occur commonly in women. 
11. CLINICAL FEATURES: 
 In our present study majority (92.3%) of the women 
presented with typical retrosternal chest pain. 30 patients had a 
typical radiation of chest pain. 40 patients had sweating. 
 Jean.C.McSweeney et al (Circulation 2003) 48 in their study 
noted that only 29.7% of women had typical chest discomfort. The 
most frequent acute symptoms were shortness of breath (57.9%), 
weakness (54.8%) and fatigue (42.9%). Chest pain was absent in 
43% women. 
 Robinson.K et al (J.Am.Coll.Cardio 1988) 49 did not agree 
with this view and found that myocardial infarction was typical in 
women also. 
 Bobby John et al (IHJ 2004) 44 in their study on 324 women 
noted typical chest pain in 139 (42.9%) women, atypical chest pain 
in 154 (47.5%) women, and no chest pain in 31 (9.6%) women. 
12. INVESTIGATIONS:  
 Creatine phosphokinase-MB was raised in 75.4% of the 
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patients which was done within 12 hours of admission. The rise was 
significant. 
 Anteroseptal myocardial infarction present in 47.7% cases 
was the most common site. Inferior wall myocardial infarction 
present in 27.7% cases was the second common site. 
 X-ray chest was taken for all cases. 20 cases had 
cardiomegaly. 22 cases had pulmonary venous congestion and 5 had 
aortic knuckle calcification.  
13. COMPLICATIONS: 
 In our study 55.4% women had complications. In the 
present series 19 cases had arrhythmias which were the most 
common complication. Most common arrhythmia was ventricular 
premature contractions. Next was ventricular tachycardia. Other 
complications were cardiogenic shock, heart block and left 
ventricular failure. 
 Robinson.K.et al (J.Am.Coll.Cardio 1988) 49 noted higher 
rate of complication in women with acute myocardial infarction. 
 Weaver et al (JAMA 1996) 50 found in his study done on 
10315 women that the nonfatal complications were more in women 
compared to men. The complications were shock (9%), congestive 
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cardiac failure (22%), serious bleeding (15%), and reinfarction 
(5.1%). 
14. MORTALITY: 
 Total mortality in the present study was 7.14% in 
Premenopausal and 7.84% in postmenopausal women. 
 Jaume Marrugat et al (JAMA 1998) 42 noticed that the 28 
day mortality rate was significantly higher among women (18.5%) 
compared to men (8.3%). Even the 6 month mortality rate was higher 
(25.8%) in women compared to men in whom it was 10.8%. 
 Viola Vaccarino et al (NEJM 1999) 51 noticed that among 
patients less than 50 years of age the mortality rate for the women 
was more than twice that for the men. The difference in the rates 
decreased with increasing age and was no longer significant after the 
age of 74. Logistic regression analysis showed that the chance of 
death was 11.1% greater for women than for men with 5year 
decrease in age. 
 K.H.Mak et al (HEART 2004) 52 noticed in their study 
done on 3497 women that the 28 day case fatality rate was greater in 
women (51.5%) with a larger sex difference evident among younger 
Malay patients. Case fatality rate was higher among women with 
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adjusted hazard ratios of 1.64 and 1.50 for 28 day and mean 4year 
follow up periods. 
 Cheng I Cheng et al (CHEST 2004) 53 in their study noticed 
that 30 day mortality in women was 14.6% which was higher when 
compared to men in whom it was 7.4%. 
 Mady Moriel et al (Arch. Int. Med 2005) 54 in their study 
done on elderly women noted that the mortality rates were 12% at 7 
days which was higher than men. 
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CONCLUSION 
 
1. The incidence of Myocardial Infarction is less common in 
women particularly in Premenopausal women and this may be 
due to protection offered by female sex hormones to 
Atherosclerosis. 
2. Risk factors like Diabetes Mellitus, Hypertension, Obesity, 
Hypercholesterolemia, and Positive family history played an 
important role in the causation of Acute Myocardial Infarction 
in women particularly in Premenopausal women. 
3. The lower incidence of Acute Myocardial Infarction in Indian 
women particularly in Premenopausal group can be attributed 
to the rarity of smoking and less frequent use of Oral 
Contraceptive Pills. 
4. Majority of women presented with typical Retrosternal chest 
pain and sweating as in the case of men. There was no major 
difference in the presenting features between the 
Premenopausal (group A) and Postmenopausal (group B) 
women. 
5. The most common site of infarction was in the Anteroseptal 
region which was present in 47.7% women. 
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6. Complications were higher (55.4%) in women. The most 
common complication of Myocardial Infarction in women was 
arrhythmias which was present in 19 cases. Ventricular 
arrhythmias were the commonest among them which was 
present in 15 cases. 
7. Mortality rates were higher in women. Total mortality in the 
present study was 7.14% in Premenopausal and 7.84% in 
Postmenopausal women.  
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SUMMARY 
 
 
 Coronary artery disease has been frequently viewed as a 
disease only of men. Carefully designed clinical trials in women with 
coronary artery disease have begun only since 1980. Now coronary 
artery disease has begun to be recognized as a leading cause of death 
in women. Risk factor of the disease and medical interventions have 
been studied thoroughly only in men. In women, use of oral 
contraceptive pills, hormone replacement therapy, menopause, 
cultural and social roles, family pressure seem to act synergistically 
with the known coronary artery disease risk factors and also 
contribute to the sex differences of the disease. 
 Age at presentation, less specific or subtle clinical 
manifestations, hence not reaching the tertiary care centre at the 
appropriate time, greater difficulties and bias in the clinical 
diagnosis, higher risks involved in angiography, angioplasty and 
coronary artery bypass graft techniques, higher incidence of cardiac 
morbidity and mortality are the major sex differences studied and 
analyzed. 
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 Once coronary artery disease develops women have no 
survival advantage over men, whatever be the age group. 
 Ventricular septal rupture, free wall rupture, congestive 
cardiac failure, recurrent myocardial infarction, bleeding with 
thrombolytic therapy is some of the common problems faced in 
women. 
 Late reference, smaller body size, fragile coronary blood 
vessels are some of the reasons attributed to high mortality and 
morbidity. 
  In the present study conducted at CMC hospital from 1st Jan 
to 31st Dec 2005 it was found out that the Myocardial Infarction was 
higher in Postmenopausal women than Premenopausal women. The 
multiplicity of risk factors was higher in the Premenopausal women. 
 Typical risk factors for male Myocardial Infarction like 
Hypertension, Diabetes Mellitus, Obesity, Hypercholesterolemia, 
Positive family history also prevailed in the females. Complication 
and mortality were on the higher side in the case of females. 
 Hence, coronary artery disease needs to be addressed as a 
special and specific issue in women. There is great scope for further 
studies regarding therapeutic interventions in women.
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MASTER CHART 
 
 
 
FH-Family History, OCP-Oral Contraceptive Pill ,H-Hypertension, DM-Diabetes Mellitus, MI-Myocardial Infarction, O-Obesity,  CPK-MB-Creatine Phosphokinase,  P-present 
AS-Anteroseptal,  AL-Anterolateral,  EA-Extensive anterior,  IL-Inferolateral,  RV-Right Ventricular,Inf-Inferior Wall,  VE- Ventricular Ectopics ,VT-Ventricular Tachycardia, 
VF- Ventricular Fibrillation, AE-Atrial Ectopics,  IstHB-Ist Degree Heart Block , CS-Cardiogenic shock, CA-Cardiac Arrest, PMD-Papillary Muscle Dysfunction,  C.Mly-
Cardiomegaly , PVC-Pulmonary Venous Congestion, CAK-Calcified Aortic Knuckle,  ↑-Raised. 
 
 
S.NO NAME 
AGE 
In 
Yrs 
1P.N
o. 
Men. 
Status F.H. 
OCP 
Use 
Smo 
king 
Tobacco 
Chewing 
Abdl 
Obesit
y 
D.
M H 
Hyper- 
Choles 
terolemia 
CP
K-
MB 
CXR 
Infarc
t 
Site 
Comp 
lication Mortality 
1 ALAGAMMAL 53 30407 PostM H      P 145 ↑ C.Mly AS   
2 AMANIAMMAL 64 31890 PostM DM   YES  P  166 ↑  AS   
3 AMBUJAM 54 35890 PostM MI       256 ↑ PVC EA VE  
4 ANTHONIAMMAL 68 36765 PostM DM/H     P P 154 ↑ C.Mly AS AE  
5 ARTHI 43 46075 PreM H      P 156 ↑ PVC/C.Mly IL   
6 ARUKANI 62 48976 PostM DM/H   YES  P P 249 ↑ PVC/C.Mly EA VT  
7 BANNARI 63 32167 PostM DM/MI     P  276  PVC EA IstHB  
8 CHENTHAMARAI 55 34217 PostM H      P 157 ↑ PVC/C.Mly AS   
9 CHINNAKANNU 65 35786 PostM        142   AL AE  
10 CHINNAMMAL 68 42876 PostM O   YES   P 145 ↑ C.Mly AS   
11 CHINTHAMANI 55 45678 PostM MI/O    P P  252 ↑ PVC AS   
12 CHITRAKALA 72 47098 PostM DM/H   YES  P P 167 ↑ CAK/PVC EA VF DIED 
13 DAVAMANI 54 47365 PostM        163 ↑  AS PMD  
14 DEVI 44 43876 PreM DM/MI    P P  292 ↑  AS VF  
15 FATHIMA 53 34569 PostM DM/H   YES P P P 289 ↑ C.Mly AS VT  
16 FARIDA 65 38762 PostM O  YES   P  251 ↑  IL   
17 FIROZ 62 40594 PostM H      P 176 ↑ PVC/C.Mly AL   
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FH-Family History, OCP-Oral Contraceptive Pill ,H-Hypertension, DM-Diabetes Mellitus, MI-Myocardial Infarction, O-Obesity,  CPK-MB-Creatine Phosphokinase,  P-present 
AS-Anteroseptal,  AL-Anterolateral,  EA-Extensive anterior,  IL-Inferolateral,  RV-Right Ventricular,Inf-Inferior Wall,  VE- Ventricular Ectopics ,VT-Ventricular Tachycardia, 
VF- Ventricular Fibrillation, AE-Atrial Ectopics,  IstHB-Ist Degree Heart Block , CS-Cardiogenic shock, CA-Cardiac Arrest, PMD-Papillary Muscle Dysfunction,  C.Mly-
Cardiomegaly , PVC-Pulmonary Venous Congestion, CAK-Calcified Aortic Knuckle,  ↑-Raised. 
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18 GEETHA 35 45632 PreM DM/HT/ MI YES    P  258 ↑ C.Mly AS VE  
19 GOUTHAMI 63 34516 PostM        156 ↑ PVC AS LVF  
20 HEMA 56 45678 PostM        178 ↑  AS   
21 ILAVARASI 64 31231 PostM        158 ↑  AS VE  
22 INDUMATHI 51 39654 PostM        156 ↑ PVC Inf+RV Ist HB  
23 INDIRA 35 46703 PreM DM/HT MI/O YES   P  P 290   AS VT  
24 INDRAKUMARI 77 47628 PostM H   YES  P P 276 ↑ PVC/C.Mly Inf+RV   
25 JAMUNA 61 47893 PostM        157 ↑   AS  
26 JEBAKUMARI 54 43508 PostM O     P  176 ↑  EA CA  
27 JOHIRA 55 42369 PostM DM/H     P P 168 ↑ C.Mly AS   
28 JOTHI 44 36781 PreM H YES   P   152  PVC AS VE  
29 KAMALAMMAL 76 33456 PostM H      P 170 ↑ C.Mly Inf   
30 KARUPAYEE 62 44444 PostM H     P  175   AS   
31 KARUPAMMAL 69 36480 PostM DM/H/O   YES P P P 275 ↑ C.Mly AL IstHB  
32 KONDAMMAL 54 37654 PostM H      P 177  C.Mly/PVC AS LVF DIED 
33 KUPPAMMAL 65 39463 PostM H/MI/O  YES YES   P 250 ↑  Inf IstHB  
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34 LALITHA 58 45790 PostM H    P  P 267  PVC Inf+RV CS DIED 
35 LATHA 44 43213 PreM H    P  P 288 ↑  Inf   
36 LAVANYA 58 33333 PostM MI       156 ↑ PVC AS   
37 MANJU 42 34590 PreM DM/O YES      148 ↑  AL VE  
38 MANJULA 79 47832 PostM DM   YES  P  150 ↑ CAK AL VT  
39 MARAGATHAM 69 45702 PostM MI/O  YES  P   262   Inf+RV VT  
40 MEGHALA 52 43567 PostM DM     P  276 ↑ PVC Inf   
41 MOHINI 45 44466 PreM DM    P P P 241 ↑ C.Mly AL VT  
42 NAGAMMAL 63 45666 PostM H/MI   YES   P 263 ↑ C.Mly AS   
43 NALINI 43 48102 PreM DM     P  150 ↑  Inf   
44 NANJAMMAL 60 34789 PostM        168 ↑ PVC AS LVF  
45 NOORJAHAN 57 37845 PostM        167 ↑  Inf   
46 PADMAKUMARI 54 35098 PostM MI/O    P   291   AS   
47 PANKAJAM 62 45877 PostM DM     P  185  PVC AS PMD  
48 PARVATHAMAL 50 47555 PostM DM/H    P P P 282 ↑  AS   
49 PARVATHI 59 34566 PostM DM/O    P P  174 ↑  AS AE  
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50 POORANI 44 47836 PreM H    P  P 152  C.Mly EA   
51 RANGAMMAL 60 45690 PostM H/O   YES P  P 266 ↑ PVC Inf+RV CS DIED 
52 RANGANAYAGI 54 32478 PostM DM   YES  P  156 ↑  Inf IstHB  
53 RASATHI 60 44556 PostM        158  CAK Inf   
54 RATHI 44 45666 PreM MI    P   276 ↑  Inf VE  
55 REKHA 64 47880 PostM DM/H/O    P P  270 ↑  AS   
56 SARANYA 44 43562 PreM H/MI YES  YES P P P 290 ↑ C.MlyPVC Inf+RV LVF DIED 
57 SENIAMMAL 63 37628 PostM        186 ↑  AS VE  
58 SELVANAYAGI 53 37650 PostM H/MI   YES P  P 289 ↑  AS   
59 SENTHAMARAI 68 46653 PostM DM   YES  P  168  C.Mly AS AE  
60 SENTHOORAM 75 47134 PostM        159 ↑ CAK Inf   
61 TAMILSELVI 72 39345 PostM        148 ↑ PVC IL   
62 THAMARAI 68 36741 PostM      P  172 ↑  EA CS  
63 URVASI 43 43756 PreM DM/O       165  PVC Inf+RV CS  
64 VANITHA 70 48356 PostM H/MI      P 164 ↑ CAK/C.Mly AS   
65 VASAVI 43 46834 PreM DM    P   175 ↑  Inf CS  
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FIG 6: COMPARISON OF INDIVIDUAL RISK FACTORS BETWEEN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN 
 
 
  
 
FIG 4: COMPARISON OF RISK FAFCTORS OF MYOCARDIAL INFARCTION IN WOMEN 
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FIG 5: COMPARISON OF MULTIPLE RISK FACTORS IN GROUP A & B 
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FIG 7: SITE OF INFARCTION 
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CORONARY CIRCULATION 
 
 
  
 
ALAGAMMAL            53yrs            IP.No.30407 
 
 
 
ECG SHOWING ACUTE ANTEROSEPTAL MYOCARDIAL INFARCTION 
 LATHA              44Yrs              IP.No.43213 
 
 
ECG SHOWING ACUTE INFERIOR WALL MYOCARDIAL INFARCTION 
 
THAMARAI            68Yrs             IP.No.36741 
 
 
                    ECG SHOWING EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION 
 
 
POORNI                          44yrs                       47836 
 
 
 
ECG SHOWING ANTERIOR WALL MYOCARDIAL INFARCTION 
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FIG 2: INCIDENCE OF MYOCARDIAL INFARCTION FOR DIFFERENT AGE 
GROUPS IN WOMEN 
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FIG 3: INCIDENCE OF POSITIVE FAMILY HISTORY FOR MI IN 
WOMEN 
 
CHINNAKANNU          65Yrs          IP.No.35786 
 
 
 
 
 
 
 
ECG SHOWING ANTEROLATERAL MYOCARDIAL 
INFARCTION 
 
 
  
 
 
X-RAY CHEST SHOWING CARDIOMEGALY 
 
 
 
X-RAY CHEST SHOWING FEATURES OF HEART FAILURE 
  
ECHO SHOWING VSD 
 
 
 
                         ECHO SHOWING MITRAL REGURGITATION   
  
 
 
 
CORONARY ANGIOGRAM AND SCHEMATIC DIAGRAM SHOWING BLOCK 
IN LEFT ANTERIOR DESCENDING ARTERY 
 
 
 
 
                   
 
 
 
 
CORONARY ANGIOGRAM SHOWING BLOCK IN PROXIMAL RIGHT 
CORONARY ARTERY AND ITS REAPPEARANCE AFTER THROMBOLYTIC 
THERAPY 
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MYOCARDIAL INFARCTION IN FEMALES 
 
NAME    AGE            SEX 
 
ADDRESS   OCCUPATION  INCOME 
 
 
 
DIAGNOSIS  IP. NO.  D.O.A. D.O.D. 
 
COMPLAINTS 
 
 
 
H/O PRESENT ILLNESS 
 
 
CHEST PAIN-TYPE, RADIATION 
SWEATING 
PALPITATION 
SYNCOPE 
DYSPNOEA 
PND, ORTHOPNOEA 
GIDDINESS 
NAUSEA & VOMITING 
 
 
PAST HISTORY 
 
SYSTEMIC HYPERTENSION  DIABETES MELLITUS 
 
COPD       TUBERCULOSIS 
 
PERSONAL HISTORY: 
 
 SMOKING, ALCOHOL. 
 
DIET: VEG/NONVEG/MIXED 
 
FAMILY HISTORY: 
 
 IHD/OBESITY/DIABETES/HYPERTENSION/HYPERLIPIDEMIA 
 
TREATMENT HISTORY:  DRUG INTAKE 
 
MARITAL HISTORY 
 
MENSTRUAL HISTORY 
 
OBSTETRIC HISTORY 
 
GENERAL EXAMINATION 
 
 OBESITY 
 DYSPNOEA 
 CYANOSIS 
 CLUBBING 
 PITTING PEDAL EDEMA 
 XANTHALESMA 
 TENDON XANTHOMAS 
 ARCUS SENILIS 
 PULSE 
 BLOOD PRESSURE 
 WAIST CIRCUMFERENCE 
 
CARDIOVASCULAR SYSTEM 
 
APICAL IMPULSE  S1  S2  S3 
 
PERICARDIAL RUB       PERIPHERALVASCULAR SYSTEM 
RESPIRATORY SYSYEM 
 
 
ABDOMEN 
 
 
CENTRAL NERVOUS SYSTEM 
 
 
FUNDUS 
 
 
INVESTIGATION 
 
 URINE ROUTINE 
 BLOOD SUGAR  
 BLOOD UREA 
 SERUM CREATININE 
 SERUM CHOLESTEROL 
 SERUM CPK-MB 
 ECG 
 CHEST X-RAY 
 ECHO 
 
 
 
 
 
